Enterprise Financial Services Corp (EFSC)’s Clovis Oncology, Inc. CLVS Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-64	Closed	-$1K	–	1063
2016 Q1	$1K	Sell	64 -40	-38%	-$847	﹤0.01%	1012
2015 Q4	$4K	Sell	104 -55	-35%	-$3.55K	﹤0.01%	793
2015 Q3	$15K	Hold	159	–	–	0.01%	459
2015 Q2	$14K	Buy	159 +34	+27%	+$2.91K	0.01%	491
2015 Q1	$9K	Hold	125	–	–	0.01%	654
2014 Q4	$7K	Buy	125 +40	+47%	+$2.1K	﹤0.01%	715
2014 Q3	$4K	Buy	85 +9	+12%	+$376	﹤0.01%	857
2014 Q2	$3K	Hold	76	–	–	﹤0.01%	979
2014 Q1	$5K	Buy	76 +12	+19%	+$881	﹤0.01%	837
2013 Q4	$4K	Hold	64	–	–	﹤0.01%	854
2013 Q3	$4K	Hold	64	–	–	﹤0.01%	831
2013 Q2	$4K	Buy	+64	New	+$2.88K	﹤0.01%	706

Other funds holding CLVS

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return